USANA Health Sciences, Inc. (USNA) Earnings History
Net Loss31 years of earnings data (1995–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
USANA Health Sciences, Inc. (USNA) Earnings Overview
As of November 8, 2026, USANA Health Sciences, Inc. (USNA) reported trailing twelve-month net income of -$21M, reflecting -73.5% year-over-year growth. The company earned $-1.15 per diluted share over the past four quarters, with a net profit margin of 1.2%.
Looking at the long-term picture, USNA's 5-year EPS compound annual growth rate (CAGR) stands at -37.0%, signaling declining earnings. The company achieved its highest annual net income of $126M in fiscal 2018.
USANA Health Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NUS (-$234M net income, 10.8% margin), NATR ($15M net income, 4.1% margin), NHTC (-$1M net income, -2.2% margin), USNA has room to improve margins relative to the peer group. Compare USNA vs NUS →
USNA Earnings vs Peers
Earnings metrics vs comparable public companies
USNA Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $11M | -74.4% | $51M | $0.58 | 1.2% | 5.5% |
| 2024 | $42M | -34.1% | $66M | $2.19 | 4.9% | 7.8% |
| 2023 | $64M | -8.0% | $93M | $3.30 | 6.9% | 10.1% |
| 2022 | $69M | -40.5% | $108M | $3.59 | 6.9% | 10.8% |
| 2021 | $117M | -6.5% | $170M | $5.73 | 9.8% | 14.3% |
| 2020 | $125M | +24.0% | $176M | $5.86 | 11.0% | 15.6% |
| 2019 | $101M | -20.4% | $146M | $4.41 | 9.5% | 13.8% |
| 2018 | $126M | +101.8% | $188M | $5.12 | 10.6% | 15.8% |
| 2017 | $63M | -37.5% | $133M | $2.53 | 6.0% | 12.7% |
| 2016 | $100M | +5.7% | $139M | $3.99 | 9.9% | 13.8% |
| 2015 | $95M | +23.5% | $142M | $3.59 | 10.3% | 15.4% |
| 2014 | $77M | -3.0% | $116M | $2.80 | 9.7% | 14.7% |
| 2013 | $79M | +19.0% | $117M | $2.78 | 11.0% | 16.3% |
| 2012 | $66M | +30.9% | $98M | $2.23 | 10.2% | 15.1% |
| 2011 | $51M | +11.2% | $77M | $1.63 | 8.7% | 13.3% |
| 2010 | $46M | +36.0% | $68M | $1.43 | 8.8% | 13.2% |
| 2009 | $34M | +12.1% | $51M | $1.09 | 7.7% | 11.6% |
| 2008 | $30M | -33.9% | $48M | $0.93 | 7.0% | 11.2% |
| 2007 | $45M | +9.8% | $71M | $1.32 | 10.7% | 16.7% |
| 2006 | $41M | +5.8% | $62M | $1.10 | 11.0% | 16.7% |
| 2005 | $39M | +26.7% | $58M | $0.99 | 11.9% | 17.8% |
| 2004 | $31M | +47.8% | $45M | $0.76 | 11.3% | 16.4% |
| 2003 | $21M | +144.8% | $31M | $0.49 | 10.4% | 15.6% |
| 2002 | $9M | +286.7% | $13M | $0.21 | 6.4% | 9.6% |
| 2001 | $2M | -23.3% | $4M | $0.06 | 1.9% | 3.7% |
| 2000 | $3M | -51.4% | $5M | $0.07 | 2.3% | 4.4% |
| 1999 | $6M | -37.9% | $14M | $0.12 | 4.6% | 10.8% |
| 1998 | $10M | +43.9% | $15M | $0.17 | 7.8% | 12.5% |
| 1997 | $7M | +32.0% | $11M | $0.12 | 7.7% | 12.4% |
| 1996 | $5M | +117.4% | $8M | $0.10 | 8.8% | 13.9% |
| 1995 | $2M | - | $4M | $0.05 | 9.4% | 14.3% |
Download Data
Export USNA earnings history in CSV or JSON format
Free sign-in required to download data
USNA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
USNA — Frequently Asked Questions
Quick answers to the most common questions about buying USNA stock.
What is USNA earnings per share (EPS)?
USNA trailing twelve-month (TTM) diluted EPS is $-1.15, reflecting -73.5% year-over-year growth. The 5-year EPS CAGR is -37.0%. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is USANA Health Sciences, Inc.'s net income?
USANA Health Sciences, Inc. (USNA) trailing twelve-month net income is $-21M as of 2025. Earnings declined -73.5% year-over-year. USANA Health Sciences, Inc. has been profitable for 31 consecutive years.
Is USNA profitable?
USNA is not currently profitable on a TTM basis, reporting a net loss of $-21M. Net margin is +1.2%. Investors should monitor for a return to profitability.
What is USNA's earnings growth rate?
USNA compound annual EPS growth rates (CAGR): 1-Year: -73.5%, 3-Year: -45.5%, 5-Year: -37.0%, 10-Year: -16.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are USNA's profit margins?
USANA Health Sciences, Inc. net profit margin is +1.2%, operating margin is +5.5%, and gross margin is +78.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is +1.8%.
Is USNA growing earnings?
USNA earnings are declining — EPS fell -73.5% year-over-year. TTM net income dropped to $-21M. This contrasts with the 5-year CAGR of -37.0%.
What was USNA's best earnings year?
USANA Health Sciences, Inc.'s highest annual net income on record is $126M, achieved in fiscal year 2018. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were USNA's earnings last quarter?
USNA's most recent reported quarter was Q3 2026. Net income was $-6M with diluted EPS of $-0.30. For a full breakdown of all quarters, see the quarterly earnings table on this page.